Stankovic Srdjan R. 4
4 · ACADIA PHARMACEUTICALS INC · Filed Jan 10, 2022
Insider Transaction Report
Form 4
Transactions
- Exercise/Conversion
Common Stock
2022-01-06+5,444→ 46,956 total - Sale
Common Stock
2022-01-06$23.05/sh−1,937$44,648→ 45,019 total - Exercise/Conversion
Restricted Stock Units
2022-01-06−5,444→ 10,889 total→ Common Stock (5,444 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
- [F3]The restricted stock units vest in four equal annual installments beginning January 6, 2021.